The Angiogenesis Foundation is the world’s first nonprofit organization dedicated to conquering disease using a groundbreaking approach based on angiogenesis, the growth of new capillary blood vessels in the body. Angiogenesis is the “common denominator” in society’s most feared diseases, including wet AMD.

The Foundation is the recognized authority, championing new developments in antiangiogenic medicine. We share this expertise to endow the public with important knowledge about their health. Understanding the science behind wet AMD and its treatment guides patients, their advocates, and ophthalmologists to understand the consequences of complacency and evidence-based need for proactive care and regularized treatments.

Based in Cambridge, Massachusetts and founded in 1994, The Angiogenesis Foundation’s goal is to help people lead healthier, longer lives by restoring balance to blood vessel growth. Through research, education, and advocacy—with patients, physicians, researchers, industry, payers, and government—we enable patients to gain access to safe and effective treatments for cancer, blinding disorders, wounds, and many other serious diseases.

As a scientific organization, The Angiogenesis Foundation is independent of any individual, institution, or commercial entity. We are committed to helping people around the world benefit from the full promise of angiogenesis-based medicine, and to make life-, limb-, and vision-saving treatments available to everyone in need